Cypress Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cypress Asset Management's GILD Position: Q4 2018 in Review
Cypress Asset Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 2,800 shares — an estimated $216K sold.
Cypress Asset Management first reported a position in GILD in Q1 2014 and held it in 19 quarters. The position peaked at $4.78M in Q2 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.
- Cypress Asset Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
- Cypress Asset Management sold 2,800 Gilead Sciences shares in Q4 2018, an estimated $216K.
- Cypress Asset Management first reported a position in Gilead Sciences in Q1 2014 and held it in 19 quarters.
- Cypress Asset Management's Gilead Sciences position peaked at $4.78M in Q2 2015.
- 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.
Based on Cypress Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.